等待開盤 09-20 09:30:00 美东时间
0.000
0.00%
X4 Pharmaceuticals (XFOR) has shared an update. X4 Pharmaceuticals, Inc. has re...
08-10 04:50
X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.01 by 4400 percent. The company reported quarterly sales of $563.000 thousand which beat
08-08 18:02
X4 Pharmaceuticals Inc: Believes It Has Sufficient Funds to Support Company Ope...
08-08 18:02
X4 Pharmaceuticals Q2 EPS USD 0.45 Vs. IBES Estimate USD 0.01
08-08 18:01
X4 Pharmaceuticals (NASDAQ:XFOR) traded sharply lower on Thursday after the biotech updated data from an ongoing Phase 2 trial for its lead candidate mavorixafor in chronic neutropenia (CN), a rare bl...
06-28 01:40
X4 Pharmaceuticals (XFOR) has issued an announcement. X4 Pharmaceuticals has sh...
06-27 20:28
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C...
06-04 04:05
Cantor Fitzgerald analyst Kristen Kluska reiterates X4 Pharmaceuticals (NASDAQ:XFOR) with a Overweight and maintains $5 price target.
05-31 22:59
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-31 22:56